Use of Oxytocin as a Preventative Treatment for PTSD by Kovalchick, Laurel V
Virginia Commonwealth University
VCU Scholars Compass
Undergraduate Research Posters Undergraduate Research Opportunities Program
2015
Use of Oxytocin as a Preventative Treatment for
PTSD
Laurel V. Kovalchick
Virginia Commonwealth University, kovalchicklv@vcu.edu
Follow this and additional works at: http://scholarscompass.vcu.edu/uresposters
Part of the Hormones, Hormone Substitutes, and Hormone Antagonists Commons, Medical
Pharmacology Commons, and the Mental Disorders Commons
© The Author(s)
This Book is brought to you for free and open access by the Undergraduate Research Opportunities Program at VCU Scholars Compass. It has been
accepted for inclusion in Undergraduate Research Posters by an authorized administrator of VCU Scholars Compass. For more information, please
contact libcompass@vcu.edu.
Downloaded from
Kovalchick, Laurel V., "Use of Oxytocin as a Preventative Treatment for PTSD" (2015). Undergraduate Research Posters. Poster 150.
http://scholarscompass.vcu.edu/uresposters/150
Use of Oxytocin as a Preventative Treatment for PTSD
Laurel Kovalchick, Virginia Commonwealth University
Mentor: Professor Mary Boyes
Abstract Results
Conclusion
Works Cited Acknowledgements
PTSD is a mental health disorder associated with maladaptive fear 
response, excessive anxiety, hyperarousal,  avoidance, and flashbacks. 
Symptoms can last for month or years, and typical treatments involve a 
combination of  psychotherapy and medications like antidepressants and 
anti-anxiety drugs.
Patients with PTSD show evidence of  dysregulated hypothalamic-
pituitary-adrenal (HPA) axis resulting in lower levels of  cortisol. Long term 
stress causes excessive secretions of  norepinephrine that may lead to 
harmful physical changes in the brain and body, such as atrophy of  the 
hippocampus and elevated blood pressure. While PTSD symptoms often 
do not begin for months following trauma, changes in hormones may 
begin much sooner.
Currently, PTSD is only diagnosed and treated after symptoms 
included in the DSM occur. Previous research has found several risk 
factors for PTSD including genetics and abnormal hormone levels 
following trauma, and these factors could be used to target and treat high-
risk individuals. Preventing PTSD would not only stop symptoms from 
occurring, but it would also prevent the damages caused by the altered 
hormone levels. 
Pharmacological treatments that regulate the HPA axis may be 
effective in preventing PTSD. Oxytocin was chosen as the focus of  
research in this study because it can be delivered to the central nervous 
system in a nasal spray with minimal side effects. 
Background
In a properly functioning HPA axis, a stressor prompts the release of  corticotropin releasing hormone from the 
hypothalamus. This hormone causes a circulation in the levels of  cortisol, a steroid glucocorticoid hormone. Cortisol 
influences memory and the release of  norepinephrine from the adrenal medulla. The elevated levels of  cortisol trigger a 
negative feedback loop in the HPA axis. 
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Changes in the brain caused by PTSD
• Increased negative feedback in HPA axis
• Lowers circulating cortisol levels to limit over-activation
• Effort to maintain homeostasis
• Sympathetic nervous system over activation
• Elevates norepinephrine levels
• Happen before PTSD onset
Oxytocin’s ability to regulate the HPA axis
• Increases perception of social support
• Inhibits the stress response
• Inhibits amygdala activity
• Decreases levels of adrenocorticotropic hormone 
• Facilitates extinction of avoidance behaviors
• Enhances plasticity of glutamatergic synapses
• New connections promote extinction
Posttraumatic stress disorder (PTSD) is a disorder triggered by experiencing 
a traumatic event. PTSD causes recurrent flashbacks of  memories that lead to 
over-consolidation that prevents extinction of  emotional and physiological 
responses to the memory. Because individuals can respond differently to trauma, 
no measures are currently practiced to prevent PTSD. By studying the changes in 
the brain before and after PTSD diagnosis, it can be hypothesized that 
treatments that regulate the hypothalamic-pituitary-adrenal (HPA) axis activity 
may prevent PTSD. Risk of  developing PTSD is associated with abnormal 
cortisol and norepinephrine levels and altered HPA axis functioning after 
trauma. New research on how stress alters the HPA axis has opened up the 
opportunity to prevent PTSD in high-risk patients. Oxytocin regulates the HPA 
axis by inhibiting amygdala activity and the fear response. Stress is also reduced 
by increased benefit received from social support. After reviewing previous 
studies on oxytocin, PTSD, and the HPA axis, it was concluded that regulation 
of  the HPA axis by oxytocin may prevent PTSD by inhibiting memory over-
consolidation and by reducing physical damage to the brain caused by abnormal 
hormone levels. Oxytocin is suitable for pharmacological studies because 
oxytocin can reach the central nervous system through intranasal spray 
application with minimal side effects. Oxytocin’s anxiolytic qualities and ability to 
alter HPA axis function call for more research to evaluate its potential 
pharmacological applications. More research is needed on regulation of  the HPA 
axis to prevent PTSD and the duration and dosage of  oxytocin treatments 
necessary to achieve sufficient HPA regulation. 
Introduction
Due to the physical damages caused by HPA dysregulation in PTSD, preventative treatments should be used for 
patients at risk of  developing PTSD. Intranasal oxytocin should be studied as a preventative pharmacological 
treatment because of  its ability to regulate the HPA axis’s response to a stressor and its lack of  harsh side effects in 
short-term treatments. Excessive secretions of  norepinephrine may cause atrophy of  the hippocampus and 
dysregulation of  the HPA axis can also lead to cardiovascular disease through increases in blood pressure. Not only 
would oxytocin treatments prevent the occurrence of  harsh side effects, but regulation of  the HPA axis would also 
prevent the physical damages associated with PTSD.
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Oxytocin is a peptide hormone that acts as a 
neurotransmitter. The hypothalamus synthesize oxytocin 
naturally, and the pituitary releases this hormone in to the 
bloodstream Administration of  oxytocin in humans has 
mostly been through intravenous infusion or nasal spray, 
and it has been commonly used to induce labor and 
enhance lactation
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